|
|
|
Volumn 13, Issue 74, 2004, Pages 233-
|
|
Drug-related risks during heat waves: Reconsider treatments in patients at risk
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3,4 METHYLENEDIOXYMETHAMPHETAMINE;
ACETAZOLAMIDE;
ADRENERGIC RECEPTOR STIMULATING AGENT;
ALCOHOL;
AMFEBUTAMONE;
AMPHETAMINE;
ANGIOTENSIN II ANTAGONIST;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ATROPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBONATE DEHYDRATASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
COCAINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EPHEDRINE;
METHYLPHENIDATE;
MONOAMINE OXIDASE INHIBITOR;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHENOTHIAZINE;
PSEUDOEPHEDRINE;
PSYCHOTROPIC AGENT;
SEROTONIN UPTAKE INHIBITOR;
SIBUTRAMINE;
TOPIRAMATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
BODY TEMPERATURE DISORDER;
CLINICAL PRACTICE;
DEHYDRATION;
EPIDEMIOLOGICAL DATA;
EXTRAPYRAMIDAL SYMPTOM;
FLUID INTAKE;
HEAT LOSS;
HEAT STROKE;
HIGH TEMPERATURE;
HUMAN;
KIDNEY FAILURE;
MEDICAL ASSESSMENT;
MORTALITY;
NOTE;
PATIENT EDUCATION;
RISK ASSESSMENT;
SUMMER;
SWEATING;
THERMAL EXPOSURE;
THERMODYNAMICS;
THERMOGENESIS;
THERMOREGULATION;
VASOCONSTRICTION;
|
|
EID: 15944401403
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|